Having trouble viewing this email? View it as a Web page. TDI adopts updates to adverse determination rules The Texas Department of Insurance has adopted updates to the rules on reviews and appeals of utilization review agent adverse determinations for prescription drugs, intravenous infusions, and step therapy protocol exception requests. These updates are to comply with changes in state law. Visit the TDI website for a copy of the adoption order.

Stay Connected with Texas Department of Insurance: